Phylogenetic Analysis of Scopulariopsis Brevicaulis Isolated From Diabetic Patients in Kirkuk City, Iraq

Lateef Mohammed, Bari; Tajer Abdullah, Iman; Hussein Mohammed, Sanaa; Beebany, Shakhawan

year 18, Issue 4 (July - August 2024) Iran J Med Microbiol 2024, 18(4): 247-256 | Back to browse issues page

Mendeley

Zotero

RefWorks

Lateef Mohammed B, Tajer Abdullah I, Hussein Mohammed S, Beebany S. Phylogenetic Analysis of Scopulariopsis Brevicaulis Isolated From Diabetic Patients in Kirkuk City, Iraq. Iran J Med Microbiol 2024; 18 (4) :247-256
URL: http://ijmm.ir/article-1-2454-en.html

Phylogenetic Analysis of Scopulariopsis Brevicaulis Isolated From Diabetic Patients in Kirkuk City, Iraq

Bari Lateef Mohammed¹

, Iman Tajer Abdullah²

, Sanaa Hussein Mohammed¹

, Shakhawan Beebany³

1- Department of Biology, College of Science, University of Kirkuk, Kirkuk, Iraq
2- Department of Biology, College of Science, University of Kirkuk, Kirkuk, Iraq , imantajer@uokirkuk.edu.iq
3- Department of Chemistry, College of Science, University of Kirkuk, Kirkuk, Iraq

Abstract: (594 Views)

Background and Aim: Scopulariopsis brevicaulis (S. brevicaulis) is an opportunistic pathogen causing both localized and systemic infections. Recent studies indicated DNA sequence variation among S. brevicaulis isolates from different clinical sources. In this study we aimed to isolate and diagnose S. brevicaulis from nail and skin samples of diabetic patients and investigate their phylogenetic diversity based on the internal transcribed spacer 1 (ITS) sequencing.
Materials and Methods: Fifty nail and skin samples were collected from diabetic patients suffering from skin lesions. Conventional diagnostic methods were utilized to identify the bacterial and fungal isolates. Fungal DNA was extracted and ITS 1 region was amplified by PCR and sequenced using Sanger method. Multiple sequence alignment and phylogenetic analysis were conducted using Clustal W and MEGA software. Finally, antifungal susceptibility test was performed by disc diffusion method.
Results: Based on the culture, microscopic evaluation, and biochemical tests, various types of bacteria and fungi were isolated. Among 50 nail and skin samples, 25 fungal isolates (50%) and 5 bacterial isolates (10%) were recovered. Interestingly, one of the fungal isolates was identified as Scopulariopsis brevicaulis. This isolate was associated with a clinical case involving a 52-year-old male. Phylogenetic analysis of the ITS region showed our isolate (Scopulariopsis brevicaulis) closely matched and clustered in the same clade as those reported in the US, differing from those reported in Iraq (Basrah), Iran, and Turkey. Furthermore, our isolate exhibited a multi-drug resistance pattern against antifungal agents.
Conclusion: This study highlights the importance of identifying S. brevicaulis in diabetic patients due to its multi-drug resistance. DNA sequencing and phylogenetic analysis revealed genetic divergence from the strains within the same country and other different countries.

Keywords: Diabetes, Fungal infection, Iraq, Onychomycosis, Phylogenetic, Scopulariopsis

Full-Text [PDF 701 kb] (160 Downloads) | | Full-Text (HTML) (112 Views)

Type of Study: Original Research Article | Subject: Medical Mycology
Received: 2024/07/7 | Accepted: 2024/09/4 | ePublished: 2024/09/29

References

1. Wu CY, Lee CH, Lin HL, Wu CS. Cutaneous granulomatous infection caused by Scopulariopsis brevicaulis. Acta Derm-Venereol. 2009;89(1):103-4. [DOI:10.2340/00015555-0575]

2. Chung WK, Sung H, Kim MN, Lee MW, Shin JH, Choi JH, et al. Treatment-resistant Scopulariopsis brevicaulis infection after filler injection. Acta Derm-Venereol. 2009;89(6):636-8. [DOI:10.2340/00015555-0713]

3. Jagielski T, Kosim K, Skora M, Macura AB, Bielecki J. Identification of Scopulariopsis species by partial 28S rRNA gene sequence analysis. Pol J Microbiol. 2013;62(3):303-6. [DOI:10.33073/pjm-2013-040]

4. Petanović M, Tomić Paradžik M, Krištof Ž, Cvitković A, Topolovac Z. Scopulariopsis brevicaulis as the cause of dermatomycosis. Acta Dermatovenerologica Croatica. 2010;18(1):8-13.

5. Kordalewska M, Brillowska-Dąbrowska A. PCR detection of Scopulariopsis brevicaulis. Pol J Microbiol. 2015;64(1):65-8. [DOI:10.33073/pjm-2015-009]

6. Kordalewska M, Jagielski T, Brillowska-Dąbrowska A. Rapid assays for specific detection of fungi of Scopulariopsis and microascus genera and Scopulariopsis brevicaulis species. Mycopathologia. 2016;181:465-74. [DOI:10.1007/s11046-016-0008-5]

7. Gupta AK, Drummond-Main C, Cooper EA, Brintnell W, Piraccini BM, Tosti A. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol. 2012;66(3):494-502. [DOI:10.1016/j.jaad.2011.02.038]

8. Iwen PC, Schutte SD, Florescu DF, Noel-Hurst RK, Sigler L. Invasive Scopulariopsis brevicaulis infection in an immunocompromised patient and review of prior cases caused by Scopulariopsis and Microascus species. Med Mycol. 2012;50(6):561-9. [DOI:10.3109/13693786.2012.675629]

9. Salmon A, Debourgogne A, Vasbien M, Clément L, Collomb J, Plénat F, et al. Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature. Clin Microbiol Infect. 2010;16(5):508-12. [DOI:10.1111/j.1198-743X.2009.02878.x]

10. Sandoval-Denis M, Sutton DA, Fothergill AW, Cano-Lira J, Gené J, Decock CA, et al. Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs. J Clin Microbiol. 2013;51(12):3937-43. [DOI:10.1128/JCM.01927-13]

11. Iwen PC, Hinrichs SH, Rupp ME. Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med Mycol. 2002;40(1):87-109. [DOI:10.1080/mmy.40.1.87.109]

12. Didehdar M, Shokohi T, Khansarinejad B, Sefidgar SA, Abastabar M, Haghani I, et al. Characterization of clinically important dermatophytes in North of Iran using PCR-RFLP on ITS region. J Med Mycol (Journal de Mycologie Médicale). 2016;26(4):345-50. [DOI:10.1016/j.mycmed.2016.06.006]

13. Stavrakieva V, Kantardjiev T, Panaiotov S, Levterova V. PCR as a method for diagnosis of Scopulariopsis brevicaulis. Probl Inf Parasit Dis. 2003:14-17.

14. Mutlu Sariguzel F, Berk E, nedret Koc A, Sav H, Aydemir G. Evaluation of CHROMagar Candida, VITEK2 YST and VITEK® MS for identification of Candida strains isolated from blood cultures. Infez Med. 2015;23(4):318-22.

15. Ellis DH, Davis S, Alexiou H, Handke R, Bartley R. Descriptions of medical fungi. 2nd ed. Adelaide, Australia: University of Adelaide; 2007.

16. Assi Kakaee AF, Mohammed BL. Molecular identification of Trichophyton mentagrophytes isolated from tinea corporis in Kirkuk City, Iraq. Casp J Environ Sci. 2024;22(1):1-8.

17. Zafar A, Jabeen K, Farooqi J. Practical guide and atlas for the diagnosis of fungal infections. 2017.

18. Salkin IF, Hollick GE, Hurd NJ, Kemna ME. Evaluation of human hair sources for the in vitro hair perforation test. J Clin Microbiol. 1985;22(6):1048-9. [DOI:10.1128/jcm.22.6.1048-1049.1985]

19. Mustafa NR, Abdullah IT, Jabbar S. Phenotypic detection of virulence determinants and antibiotics resistance in Staphylococcus aureus from different clinical isolates in Kirkuk city. HIV Nursing. 2023;23(1):891-9.

20. Mushıb MK, Ahmed WK, Gaffaroğlu M. Dermatofitlerin İzolasyonu, Moleküler Tanımlanması ve Bununla İlişkili Bazı Çevresel Faktörlerin İncelenmesi. Kırşehir Ahi Evran Üniversitesi Fen Bilimleri Enstitüsü Dergisi. 2023;1(1):1-9.

21. Hall TA, editor BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. In Nucleic acids symposium series; Vol. 41, No. 41. Oxford, England: Oxford University Press. 1999. pp. 95-8.

22. Katoh K, Kuma K, Toh H, Miyata T. MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 2005;33(2):511-8. [DOI:10.1093/nar/gki198]

23. Ronquist F, Teslenko M, Van Der Mark P, Ayres DL, Darling A, Höhna S, et al. MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space. Syst Biol. 2012;61(3):539-42. [DOI:10.1093/sysbio/sys029]

24. Nweze EI, Mukherjee PK, Ghannoum MA. Agar-based disk diffusion assay for susceptibility testing of dermatophytes. J Clin Microbiol. 2010;48(10):3750-2. [DOI:10.1128/JCM.01357-10]

25. Clinical and Laboratory Standards Institute. Method for Antifungal Disk Diffusion Susceptibility Testing of Non-dermatophyte Filamentous Fungi. Approved Standard. CLSI document M51-A1. Clinical and Laboratory Standards Institute, Wayne, PA. 2010.

26. Alam N, Kim JH, Shim MJ, Lee UY, Lee TS. Mycelial propagation and molecular phylogenetic relationships of commercially cultivated Agrocybe cylindracea based on ITS sequences and RAPD. Mycobiology. 2010;38(2):89-96. [DOI:10.4489/MYCO.2010.38.2.089]

27. Ara I, Sultana R, Chanda IJ, Alam N. First report of fungus Scopulariopsis brevicaulis from fresh water dry shrimp in Bangladesh. Bangladesh J Zool. 2020;48(1):203-9. [DOI:10.3329/bjz.v48i1.47889]

28. Macura AB, Skóra M. 21-year retrospective study of the prevalence of Scopulariopsis brevicaulis in patients suspected of superficial mycoses. Adv Dermatology Allergology (Postępy Dermatologii i Alergologii). 2015;32(3):189-94. [DOI:10.5114/pdia.2014.40965]

29. Azar LG, Khaddam W, Yaseen S. Prevalence of Non-Dermatophytic Molds in Toenails among Diabetic Patients in Homs, Syria. Iraqi J Sci. 2023;64(7):3242-50. [DOI:10.24996/ijs.2023.64.7.5]

30. Lee MH, Hwang SM, Suh MK, Ha GY, Kim H, Park JY. Onychomycosis caused by Scopulariopsis brevicaulis: report of two cases. Ann Dermatol. 2012;24(2):209-13. [DOI:10.5021/ad.2012.24.2.209]

31. Dhib I, Fathallah A, Yaacoub A, Zemni R, Gaha R, Said MB. Clinical and mycological features of onychomycosis in central Tunisia: a 22 years retrospective study (1986-2007). Mycoses. 2013;56(3):273-80. [DOI:10.1111/myc.12016]

32. Bassiri-Jahromi S, Khaksar AA. Nondermatophytic moulds as a causative agent of onychomycosis in Tehran. Indian J Dermatol. 2010;55(2):140-3. [DOI:10.4103/0019-5154.62743]

33. Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol. 2000;42(2):217-24. [DOI:10.1016/S0190-9622(00)90129-4]

34. Mügge C, Haustein UF, Nenoff P. Causative agents of onychomycosis-a retrospective study. J Ger Soc Dermatol (Journal der Deutschen Dermatologischen Gesellschaft). 2006;4(3):218-28. [DOI:10.1111/j.1610-0387.2006.05877.x]

35. Bonifaz A, Cruz-Aguilar P, Ponce RM. Onychomycosis by molds. Report of 78 cases. Eur J Dermatol. 2007;17(1):70-2.

36. Naik SP, Mangala G, Lava R. Spectrum of dermatophytic fungal infection in tertiary care hospital, davanagere. Int J Curr Microbiol App Sci. 2019;8(03):165-71. [DOI:10.20546/ijcmas.2019.803.023]

37. Skóra M, Macura AB. In vitro antifungal susceptibility testing of Scopulariopsis brevicaulis strains using agar diffusion method. Ann Parasitol (Wiadomoœci Parazytologiczne). 2011;57(2):111-7.

38. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzón A, Rodriguez-Tudela JL. Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents. Antimicrob Agents Chemother. 2003;47(7):2339-41. [DOI:10.1128/AAC.47.7.2339-2341.2003]

39. Skóra M, Bulanda M, Jagielski T. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species. Antimicrob Agents Chemother. 2015;59(9):5827-9. [DOI:10.1128/AAC.00978-15]

40. Skóra M, Macura AB, Bulanda M. In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates. Med Mycol. 2014;52(7):723-7. [DOI:10.1093/mmy/myu039]

41. Santos DA, Hamdan JS. In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes. Med Mycol. 2006;44(4):357-62. [DOI:10.1080/13693780500536893]

42. Pérez-Cantero A, Guarro J. Current knowledge on the etiology and epidemiology of Scopulariopsis infections. Med Mycol. 2020;58(2):145-55. [DOI:10.1093/mmy/myz036]